Ben is Healthcare Practice Lead, US at TLGG and has helped organizations of various sizes manage innovation initiatives, develop investment strategies, and plan for digital transformation. As the first employee of Amgen’s Berlin Technology and Innovation Hub – a corporate innovation center focused on emerging digital health technologies – he helped lay the groundwork for partnership screening and identification of emerging technology to support commercial innovation priorities. Previously, he was Senior Manager for External Affairs with TB Alliance, a biotech using public-private partnerships and a virtual R&D model to develop new TB therapies. In that role he oversaw fundraising, business development, and strategic partnership initiatives. He holds a Certificate of Achievement in Alliance Management (CA-AM).
By building greater understanding of context and flexibility into alternative payment models and enabling providers to make data-driven choices, we can begin to address inequities burdening VBC and help ensure APMs remain viable and enticing for healthcare providers.
When developing tools to tackle a public health threat, product developers don’t have the luxury of not accounting for the needs of the most vulnerable and marginalized; in fact, those people are often the product’s core market.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.